London, United Kingdom

Ahuva Nissim

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ahuva Nissim: Innovator in Affinity Reagent Libraries and Antibody Therapeutics

Introduction

Ahuva Nissim is a prominent inventor based in London, GB. She has made significant contributions to the field of biochemistry, particularly in the development of affinity reagents and therapeutic antibodies. With a total of two patents to her name, her work has the potential to impact medical diagnostics and treatment.

Latest Patents

Ahuva Nissim's latest patents include a method for generating an affinity reagent library and a composition comprising an antibody against oxidized Collagen II. The first patent outlines a method that involves determining structural elements of a ligand that interact with a target protein, producing a library of peptides, and grafting these peptides into an affinity reagent molecule. The second patent provides a composition that includes an antibody or fragment against oxidized Collagen II, which is conjugated to a pharmaceutically active moiety, and highlights its use in diagnosing and treating arthropathies.

Career Highlights

Throughout her career, Ahuva has worked at esteemed institutions such as the University of London and the University of Kent. Her research has focused on innovative methods to enhance the efficacy of therapeutic agents, particularly in the context of autoimmune diseases.

Collaborations

Ahuva has collaborated with notable colleagues, including John Marshall and Mark Howard. These partnerships have contributed to her research and the advancement of her patented technologies.

Conclusion

Ahuva Nissim's contributions to the fields of affinity reagents and antibody therapeutics demonstrate her innovative spirit and dedication to improving medical science. Her patents reflect her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…